These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 4871666)
41. Treatment of primary dysmenorrhoea with benorylate. Prasad R Practitioner; 1980 Mar; 224(1341):325-7. PubMed ID: 6105649 [No Abstract] [Full Text] [Related]
42. [Comparative study of 2 different types of hormone therapy in dysmenorrhea]. Sereno Coló JA Gac Med Mex; 1967 Jul; 97(7):827-35. PubMed ID: 4305128 [No Abstract] [Full Text] [Related]
43. [Indications for the "2-phase-method" in gynecology]. Kaiser R; Mehring W Geburtshilfe Frauenheilkd; 1966 Dec; 26(12):1558-69. PubMed ID: 5973351 [No Abstract] [Full Text] [Related]
44. [Feedback--regulation mechanisms using a multiple graded mestranol-norethisterone sequential preparation in XO Turner's syndrome]. Roll H; Breckwoldt M; Amann K Arch Gynecol; 1979 Jul; 228(1-4):575-6. PubMed ID: 485482 [No Abstract] [Full Text] [Related]
45. [New possibilities in the conservative treatment of nasopharyngeal angiofibroma]. Mülfay M; Draşoveanu C; Mülfay G; Florea C; Rodean A Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1982; 27(4):247-53. PubMed ID: 6192468 [No Abstract] [Full Text] [Related]
46. Proceedings: Studies in the management of the climacteris. Moore B; Gustafson R; Studd JW J Obstet Gynaecol Br Commonw; 1974 Dec; 81(12):1005-6. PubMed ID: 4452919 [No Abstract] [Full Text] [Related]
47. Significance of dysmenorrhea in infertility. Report of a preliminary study of therapy with a sequential estrogen-progestagen regimen. Roland M; Clyman M; Decker A; Ober WB Pac Med Surg; 1966; 74(3):135-8. PubMed ID: 4160710 [No Abstract] [Full Text] [Related]
50. Dydrogesterone in teenage dysmenorrhoea. A multicentre trial in general practice. Gould CH Practitioner; 1979 May; 222(1331):718-23. PubMed ID: 384386 [No Abstract] [Full Text] [Related]
51. [Treatment of dysmenorrhea with Pyrasanone]. Baldi C; D'Ajello M; Balbi GC Minerva Ginecol; 1983 Apr; 35(4):247-50. PubMed ID: 6350940 [No Abstract] [Full Text] [Related]
52. Mood and behavioral changes associated with the use of the oral contraceptive agents. A review of the literature. Glick ID Psychopharmacologia; 1967; 10(5):363-74. PubMed ID: 4871582 [No Abstract] [Full Text] [Related]
57. Control of paroxysmal ventricular tachycardia with oral contraceptives. Gorfinkel HJ; O'Driscoll RG Chest; 1973 Aug; 64(2):279-80. PubMed ID: 4725090 [No Abstract] [Full Text] [Related]
58. [Clinical use of Nc 123, (1-methyl-2-[2-(2-methylsulfinyldibenzothiazinyl-10)-ethyl-1]-piperidine) in autonomic stigmata and dysmenorrhea]. Yamamoto H; Ochiai K; Maruyama H Sanfujinka No Jissai; 1969 Jul; 18(7):671-6. PubMed ID: 4902244 [No Abstract] [Full Text] [Related]
59. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: results from two studies on oestrogen-related symptoms and dysmenorrhoea. Ahrendt HJ; Karckt U; Pichl T; Mueller T; Ernst U Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):354-61. PubMed ID: 17853159 [TBL] [Abstract][Full Text] [Related]
60. [Clinical study of norethisterone acetate in functional metrorrhagia and in pre- and permenstrual painful syndromes]. Anglade JP Therapie; 1972; 27(5):773-7. PubMed ID: 4675625 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]